LINC 2016 – iVascular Scientific Program
First patient included in the Effpac trial on 01 / 09 / 2015 at Universitatsklinikum jena (GER)
What happened at LINC 2015 from iVascular s standpoint
Phase III multicenter randomized controlled trial to assess the effectiveness of paclitaxel-coated luminor® Balloon Catheter versus uncoated balloon catheter in the superficial femoral and popliteal arteries to prevent vessel restenosis or reocclusion
iVascular is present at the 4th edition of GulfPCR, the most relevant Congress in Hemodynamics and Interventional Cardiology in the Middle East.
iVascular announces the launch of its range of drug-eluting balloons (Drug Elutting Balloon , DEB) with immediate worldwide availability.